Maravai LifeSciences(MRVI) - 2024 Q1 - Earnings Call Presentation

NASDAQ: MRVI May 8, 2024 03 Financial Results & Guidance Forward Looking Statements and Use of Non-GAAP Financial Measures The trademarks included herein are the property of the owners thereof and are used for reference purposes only. Such use should not be construed as an endorsement of the products or services of Maravai LifeSciences Holdings, Inc. and its subsidiaries. 3 ADJUSTED EBITDA1 $8 M Q1 2024 Financial Results Agenda 02 Business Highlights Trey Martin, Chief Executive Officer 04 Q&A Session Trey ...